Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification and Characterization of Cannabidiol as an OX1R Antagonist by Computational and In Vitro Functional Validation
Rosa Maria Vitale, Fabio Arturo Iannotti, Aniello Schiano Moriello, et al.
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1134-1134
Open Access | Times Cited: 11

Showing 11 citing articles:

THC and CBD: Similarities and differences between siblings
Nephi Stella
Neuron (2023) Vol. 111, Iss. 3, pp. 302-327
Open Access | Times Cited: 54
Orexin receptor antagonists in the pathophysiology and treatment of sleep disorders and epilepsy
Mohammad Sheibani, Maryam Shayan, Mina Khalilzadeh, et al.
Neuropeptides (2023) Vol. 99, pp. 102335-102335
Closed Access | Times Cited: 18
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders
Alessandro Bonifazi, Fabio Del Bello, Gianfabio Giorgioni, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1607-1667
Closed Access | Times Cited: 13
Antagonization of OX1 Receptor Potentiates CB2 Receptor Function in Microglia from APPSw/Ind Mice Model
Iu Raïch, Joan Biel Rebassa, Jaume Lillo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12801-12801
Open Access | Times Cited: 10
International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology
Jyrki P. Kukkonen, Laura H. Jacobson, Daniël Hoyer, et al.
Pharmacological Reviews (2024), pp. PHARMREV-000953
Open Access | Times Cited: 1
Analgesic Properties of Next-Generation Modulators of Endocannabinoid Signaling: Leveraging Modern Tools for the Development of Novel Therapeutics
Simar Singh, Kaylin J. Ellioff, Michael R. Bruchas, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 391, Iss. 2, pp. 162-173
Closed Access | Times Cited: 1
Thermodynamics and transport properties of CBD and Δ9-THC: A first attempt using molecular dynamics
Luis F. Salas-Guerrero, Cristian Buendía‐Atencio, Gustavo A. Orozco
Journal of Molecular Liquids (2022) Vol. 371, pp. 121048-121048
Closed Access | Times Cited: 5
Cannabidiol as a candidate pharmacotherapy for sleep disturbance in alcohol use disorder
Marie Gendy, Benício N. Frey, Michael Van Ameringen, et al.
Alcohol and Alcoholism (2023) Vol. 58, Iss. 4, pp. 337-345
Closed Access | Times Cited: 2
Cannabinoid-based Pharmacology for the Management of Substance Use Disorders
Miguel Á. Luján, Younghoon Kim, Linlin Zhang, et al.
Current topics in behavioral neurosciences (2024)
Closed Access
GRU-based de novo molecular generation and combinatorial virtual screening of OX1R antagonists
Xiaoqi Liang, Mei Hu, Minyao Qiu, et al.
Chemometrics and Intelligent Laboratory Systems (2022) Vol. 229, pp. 104638-104638
Closed Access | Times Cited: 1
Emerging pharmacological treatments for cannabis use disorder
Marlon Danilewitz
International Journal of Drug Policy (2022) Vol. 110, pp. 103850-103850
Closed Access
Page 1

Scroll to top